[RGLS] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -9.26%
YoY- -21.66%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,139 -6,795 -7,551 -7,258 -6,718 -7,133 -8,628 -11.87%
Tax -45 1 -12 83 1 214 1 -
NP -7,094 -6,796 -7,539 -7,341 -6,719 -7,133 -8,628 -12.24%
Tax Rate - - - - - - - -
Total Cost 7,094 6,796 7,539 7,341 6,719 7,133 8,628 -12.24%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.42 -0.40 -0.50 -0.50 -0.46 -0.67 -0.99 -43.56%
EPS Diluted -0.42 -0.40 -0.50 -0.50 -0.46 -0.67 -0.99 -43.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.